We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Janssen Biotech is suing Celltrion and Hospira in the latest of a series of lawsuits related to its blockbuster Remicade (infliximab) therapy. Read More
GlaxoSmithKline and ViiV Healthcare redeemed a priority review voucher for their application for a single-tablet antiretroviral regimen of Tivicay (dolutegravir) and Edurant (rilpivirine) for maintenance treatment of HIV-1 infections. The voucher allows for an expedited six-month review — cutting four months from the standard review. Read More
Following two other firms, Pfizer filed its own petitions with the PTO over a Herceptin patent owned by Genentech, as it continues to develop its biosimilar. Read More
The Department of Justice announced plans to review the Drug Enforcement Administration’s efforts to combat the spread of illegal opioid use through the agency’s enforcement actions against industry companies. Read More
The Supreme Court’s ruling this week on a patent dispute over printer toner cartridges could have wider effects on the pharmaceutical industry, international sales and product reimportation. Read More